Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 62.70
+0.20 (0.32%)
At close: Dec 24, 2025
BME:ROVI Market Cap
BME:ROVI has a market cap or net worth of €3.21 billion as of December 26, 2025. Its market cap has decreased by -0.56% in one year.
Market Cap
3.21B
Enterprise Value
3.29B
Revenue
724.20M
Ranking
n/a
PE Ratio
26.47
Stock Price
€62.70
Market Cap Chart
Since December 18, 2007, BME:ROVI's market cap has increased from 147.07M to 3.21B, an increase of 2,080.72%. That is a compound annual growth rate of 18.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 3.21B | -0.40% |
| Dec 31, 2024 | 3.22B | 0.22% |
| Dec 29, 2023 | 3.21B | 66.93% |
| Dec 30, 2022 | 1.92B | -53.49% |
| Dec 30, 2021 | 4.14B | 97.10% |
| Dec 31, 2020 | 2.10B | 55.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.68B |
| Almirall | 2.75B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.32B |
| Clínica Baviera | 763.78M |
| Oryzon Genomics | 250.75M |
| Prim, S.A. | 224.61M |
| Laboratorio Reig Jofre | 209.99M |